Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Treatment

CART4-34 therapy

Oncologic Therapy

CART4-34 therapy is an experimental chimeric antigen receptor T cell treatment that targets the IGHV4-34 B cell receptor, developed to treat certain B-cell lymphomas and autoimmune diseases such as systemic lupus erythematosus. A patient's own T cells are modified to express a chimeric antigen receptor based on the 9G4 antibody, which binds IGHV4-34 on malignant or disease-causing B cells; because IGHV4-34 appears on only about five percent of normal B cells, CART4-34 is designed to spare most healthy B cells, unlike CD19-targeted CAR T therapies, which eliminate a much broader population of B cells and suppress the immune system more broadly. As of 2026, CART4-34 remains in preclinical development, with cell-line and mouse-model studies reporting cancer-killing effects similar to CD19 CAR T therapy but with reduced off-target damage, and plans for phase 1 trials in lymphoma and lupus.

Facts
Classification
Status
Standard of Care 1
Origin Year
2023 2
CART4-34 therapy
Filter Results1 entry
FAQs

How is CART4-34 different from CD19 CAR T therapy?

It targets IGHV4-34 rather than CD19 and is designed to spare most healthy B cells.

CD19 CAR T therapy targets a marker found on both healthy and disease-causing B cells, so it eliminates B cells even when they are not harmful. CART4-34 instead targets the IGHV4-34 B cell receptor, and it is designed to spare most healthy B cells.
Connections

Treats

Source CART4-34 therapy (Wikipedia)
Sources
1. Wikipedia
Wikipedia contributors, Wikimedia Foundation
2. CART4-34 therapy (Wikipedia)
  • https://en.wikipedia.org/wiki/CART4-34_therapy, lead section
    CART4-34 therapy is an experimental chimeric antigen receptor T cell therapy that targets the IGHV4-34 B cell receptor.
  • Section: History (origin-year)
    University of Pennsylvania researchers first presented CART4-34 in 2023.
  • Treats: Systemic Lupus Erythematosus, Lead: treats Systemic Lupus Erythematosus
    It attempts to treat certain B-cell lymphomas and autoimmune diseases such as systemic lupus erythematosus (SLE).
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.

View At A Past Year

Choose a year to see this entry's facts and connections as the atlas records them at that moment: what it held then, what it held instead, and what it had not yet adopted. Choose Present for the current record.